Qinwei Yu

626 total citations
52 papers, 446 citations indexed

About

Qinwei Yu is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Qinwei Yu has authored 52 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Epidemiology and 13 papers in Oncology. Recurrent topics in Qinwei Yu's work include Drug Transport and Resistance Mechanisms (11 papers), Liver Disease Diagnosis and Treatment (11 papers) and Natural Compounds in Disease Treatment (9 papers). Qinwei Yu is often cited by papers focused on Drug Transport and Resistance Mechanisms (11 papers), Liver Disease Diagnosis and Treatment (11 papers) and Natural Compounds in Disease Treatment (9 papers). Qinwei Yu collaborates with scholars based in China, United States and Pakistan. Qinwei Yu's co-authors include Zhenzhou Jiang, Luyong Zhang, Kechun Liu, Yun Zhang, Ming Yan, Yu Cai, Jie Hu, Ting Xiang, Ziqiao Yuan and Zihang Yuan and has published in prestigious journals such as Chemosphere, British Journal of Cancer and Pharmacology & Therapeutics.

In The Last Decade

Qinwei Yu

46 papers receiving 442 citations

Peers

Qinwei Yu
Qinwei Yu
Citations per year, relative to Qinwei Yu Qinwei Yu (= 1×) peers Yining Lin

Countries citing papers authored by Qinwei Yu

Since Specialization
Citations

This map shows the geographic impact of Qinwei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinwei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinwei Yu more than expected).

Fields of papers citing papers by Qinwei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinwei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinwei Yu. The network helps show where Qinwei Yu may publish in the future.

Co-authorship network of co-authors of Qinwei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Qinwei Yu. A scholar is included among the top collaborators of Qinwei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinwei Yu. Qinwei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Qinwei, et al.. (2025). Luteolin modulates liver macrophage subtype polarization and play protective role in sepsis induced acute hepatic injury. Inflammation Research. 74(1). 59–59. 5 indexed citations
2.
Wang, Xinyi, Xiaoming Liu, Jingwen Li, et al.. (2025). Human-in-the-loop machine learning-based quantitative assessment of hemifacial spasm based on volumetric interpolated breath-hold examination MR. British Journal of Radiology. 98(1168). 562–570.
3.
Jin, Ming, Wenwen Xin, Li Sun, et al.. (2025). Fenofibrate promotes erucic acid metabolism by peroxisome enzyme EHHADH activation alleviating high-fat diet–induced steatotic liver disease. Molecular Pharmacology. 107(7). 100047–100047.
4.
Zhang, Yuqiao, Hua He, Qinwei Yu, et al.. (2025). Genetic diversity and reproductive trait selection signal analysis of Bohuai goats based on whole genome sequencing. BMC Genomics. 26(1). 693–693.
5.
Wang, Jiwei, et al.. (2025). Relationship between metabolic dysfunction-associated steatotic liver disease and sarcopenia: A systematic review and meta-analyses. Clinical Nutrition ESPEN. 68. 679–690. 2 indexed citations
6.
Wang, Jie, Zihang Yuan, Haoran Zhang, et al.. (2025). Obeticholic acid exacerbates liver injury through hepatocyte-mediated release of HMGB1 by inducing lysosomal membrane permeabilization in cholestasis. Chemico-Biological Interactions. 421. 111752–111752.
7.
Hu, Wanting, Lei Zhao, Xihua Li, et al.. (2024). Diarylpropionitrile-stimulated ERβ nuclear accumulation promotes MyoD-induced muscle regeneration in mdx mice by interacting with FOXO3A. Pharmacological Research. 208. 107376–107376. 2 indexed citations
8.
Li, Jingwen, Xinyu Hu, Qinwei Yu, et al.. (2024). NR1H4 ameliorates Parkinson’s disease via inhibiting astrocyte activation and neuroinflammation in a CEBPβ/NF-κB dependent manner. International Immunopharmacology. 142(Pt A). 113087–113087. 5 indexed citations
9.
Duan, Xiaoyu, Qinwei Yu, Long Liu, et al.. (2024). Insomnia in Parkinson’s Disease: Causes, Consequences, and Therapeutic Approaches. Molecular Neurobiology. 62(2). 2292–2313. 10 indexed citations
10.
Zhang, Qin, Jiwei Wang, Yingying Miao, et al.. (2024). Novel Dual PPAR δ/γ Partial Agonist Induces Hepatic Lipid Accumulation through Direct Binding and Inhibition of AKT1 Phosphorylation, Mediating CD36 Upregulation. Chemical Research in Toxicology. 37(9). 1574–1587. 2 indexed citations
11.
Wang, Changling, et al.. (2023). Obeticholic acid protects against lithocholic acid-induced exogenous cell apoptosis during cholestatic liver injury. Life Sciences. 337. 122355–122355. 7 indexed citations
12.
Huang, Xin, et al.. (2023). Psoralen Ameliorates Acetaminophen-Induced Acute Liver Injury by Inhibiting the Enzymatic Activity of CYP2E1. Revista Brasileira de Farmacognosia. 33(5). 1060–1071. 1 indexed citations
13.
Zhao, Wen, et al.. (2023). Total glucosides of Rhizoma Smilacis Glabrae: a therapeutic approach for psoriasis by regulating Th17/Treg balance. Chinese Journal of Natural Medicines. 21(8). 589–598. 7 indexed citations
14.
Yu, Qinwei, Tao Zheng, Li Liu, et al.. (2023). Obstructive sleep apnea in Parkinson's disease: A prevalent, clinically relevant and treatable feature. Parkinsonism & Related Disorders. 115. 105790–105790. 15 indexed citations
15.
Yu, Qinwei, et al.. (2022). Research progress on Mincle as a multifunctional receptor. International Immunopharmacology. 114. 109467–109467. 13 indexed citations
16.
Li, Miao, Qian Lü, Xue Fan, et al.. (2022). Fatostatin inhibits SREBP2-mediated cholesterol uptake via LDLR against selective estrogen receptor α modulator-induced hepatic lipid accumulation. Chemico-Biological Interactions. 365. 110091–110091. 12 indexed citations
17.
Yu, Qinwei, et al.. (2021). A rare case of adult herpes simplex encephalitis complicated with rhabdomyolysis. BMC Infectious Diseases. 21(1). 1 indexed citations
18.
Yu, Qinwei, Yun Zhang, Kechun Liu, et al.. (2019). Tamoxifen-induced hepatotoxicity via lipid accumulation and inflammation in zebrafish. Chemosphere. 239. 124705–124705. 41 indexed citations
19.
Yu, Qinwei, Zhenzhou Jiang, & Luyong Zhang. (2018). Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease. Pharmacology & Therapeutics. 190. 81–90. 47 indexed citations
20.
Hu, Jie, Qinwei Yu, Fang Zhao, et al.. (2015). Protection of Quercetin against Triptolide-induced apoptosis by suppressing oxidative stress in rat Leydig cells. Chemico-Biological Interactions. 240. 38–46. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026